Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tailinfang for recurrent urinary tract infection
ChiCTR1800018350Phase 2Recruiting
- Sponsor
- Shanghai Municipal Hospital of Traditional Chinese Medicine
- Start
- Sep 2018
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Tailinfang in urinary tract infection (UTI) (2 arms), sponsored by Shanghai Municipal Hospital of Traditional Chinese Medicine. Primary endpoints: Urine routine, Midstream urine culture and 3 more. Started Sep 2018; status: recruiting.
02
Drugs
Tailinfang
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on ChiCTR1800018350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018350.